fig3

Figure 3. Enrichment analysis visualization. (A) Biological process enrichment results; (B) CC enrichment results; (C) MF enrichment results; (D) Pathway enrichment results; (E and F) LYZ’s different effects on the biological functions and pathways of DKD. CC: Cellular components; MF: molecular functions; LYZ: lysozyme; DKD: diabetic kidney disease; NIK: nuclear factor kappa-light-chain-enhancer of activated B cells-inducing kinase; NF-kappaB: nuclear factor kappa-light-chain-enhancer of activated B cells; VEGF: vascular endothelial growth factor; PPAR: peroxisome proliferator-activated receptor.